US Patent 7329668 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
Patent 7329668 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Fred Christopher Zusi0
Makonen Belema0
William J. Pitts0
Xuejie Yang0
Yuping Qiu0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+114 characters)
Article
Patent abstract
The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I),
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07329668 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same US Patent 7329668 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
Infobox
Patent Number
07329668
Patent Number
7329668
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07329668 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07329668
Date of patent
February 12, 2008
Patent application number
10785612
Date Filed
February 24, 2004
Patent primary examiner
Find more entities like US Patent 7329668 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
